Supplemental Table 1 - Glucagon-like Peptide-1 Receptor Agonist Use in Patients with Psoriasis is Associated with Lower Incidence of Atherosclerotic Cardiovascular Disease

Supplemental Table 1. Baseline characteristics of GLP1-RA cohort and GLP1-RA-naïve cohort before and after propensity-score matching (PSM). Bold standard difference indicates standard difference (std diff) > 0.1.